Welcome to our dedicated page for McKesson SEC filings (Ticker: MCK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking opioid litigation accruals, thin distribution margins, and segment revenue shifts across McKesson’s 300-page annual report is no small task. Hidden in each 10-K or 8-K are critical clues about cash-flow timing, specialty drug pricing, and how the company’s vast pharmaceutical distribution network manages working capital. That complexity leaves many investors asking, “Where do I even start with McKesson SEC filings explained simply?”
Stock Titan solves that problem. Our platform pairs real-time EDGAR feeds with AI-powered summaries that translate technical disclosures into plain English. Whether you need the latest McKesson quarterly earnings report 10-Q filing, a McKesson 8-K material events explained alert on opioid settlements, or McKesson insider trading Form 4 transactions minutes after they post, we surface the facts and context automatically. You’ll see concise highlights of revenue by distribution segment, inventory turns, and litigation reserve movements—without digging through footnotes.
Use cases span every professional need: monitor McKesson executive stock transactions Form 4 before material announcements, compare gross-margin trends quarter over quarter, or dive into the McKesson proxy statement executive compensation to evaluate incentive alignment. Our coverage includes every form—from a McKesson annual report 10-K simplified to McKesson Form 4 insider transactions real-time—updated the moment they reach EDGAR. Understanding McKesson SEC documents with AI means investors, analysts, and compliance teams gain clear, immediate insights for confident decisions.
Tyler Brian S., who is listed as Chief Executive Officer and a director of McKesson Corporation (MCK), reported a sale of 11,930 shares of McKesson common stock on 08/15/2025 at a price of $677.76 per share. After the reported transaction he beneficially owned 15,942 shares directly and 215.2803 shares indirectly through the McKesson Corporation 401(k) Retirement Savings Plan.
The filing indicates the sale was made pursuant to a previously adopted plan dated November 8, 2024 and the form was signed by an attorney-in-fact on 08/19/2025. The report includes the reporting persons address in Irving, Texas, and the document is a Section 16 Form 4 disclosure of changes in beneficial ownership.
Form 144 filed for McKesson Corporation (MCK) documents a proposed sale of 11,930 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $8,085,676.80. The 11,930 shares were all acquired as restricted stock vesting on 05/20/2025 (9,930 shares), 05/23/2025 (667 shares), and 05/24/2025 (1,333 shares) as compensation. The notice shows an approximate sale date of 08/15/2025 and names Fidelity Brokerage Services LLC as the broker. The filing also reports insider sales during the past three months by Brian S. Tyler totaling 38,741 shares sold on 06/06/2025 and 07/11/2025 for combined gross proceeds of $27,390,275.49. The form includes the required representation that the seller does not possess undisclosed material adverse information.
Rutledge Napoleon B. Jr., SVP, Controller & CAO of McKesson Corporation (MCK), reported a sale of common stock under a pre-existing Rule 10b5-1 trading plan. The filing shows a transaction on 08/08/2025 in which 329 shares were sold at $663.67 per share, leaving the reporting person with 657 shares held directly. The form indicates the sale was executed pursuant to a plan adopted February 7, 2025, and the form was signed by an attorney-in-fact on 08/11/2025. The filing contains only this single non-derivative sale disclosure and does not provide additional company financial information.
McKesson Corporation (MCK) filed a Current Report on Form 8-K dated August 6, 2025. The Company states it furnished its preliminary results for the quarter ended June 30, 2025, which are attached as Exhibit 99.1 (earnings release). The filing clarifies that the information, including Exhibit 99.1, is furnished to the SEC and shall not be deemed "filed" under Section 18 of the Exchange Act or incorporated by reference except by specific reference.
Key filing details:
- Report date: August 6, 2025
- Exhibits filed: 99.1 (earnings release) and 104 (iXBRL cover page)
- Signed by: Britt J. Vitalone, Executive Vice President and Chief Financial Officer
- Securities listed on NYSE: Common stock (MCK), 1.500% Notes due 2025 (MCK25), 1.625% Notes due 2026 (MCK26), 3.125% Notes due 2029 (MCK29)
McKesson Corporation (NYSE: MCK) filed an 8-K summarizing the 30 July 2025 Annual Meeting results (Item 5.07).
- All 12 director nominees were re-elected; support exceeded 95% of votes cast, with only ~0.9-4.7 m "against" votes and 10.3 m broker non-votes per nominee.
- Shareholders ratified Deloitte & Touche LLP as independent auditor for FY 2026 by a 92% majority (102.2 m for / 8.6 m against / 0.1 m abstain).
- The advisory say-on-pay proposal also passed with ~92% approval (91.8 m for / 8.0 m against / 0.8 m abstain).
No additional business, strategic announcements or financial guidance were disclosed. The outcome signals continued investor confidence in board composition, executive pay and audit oversight but carries limited immediate valuation impact.
FAQ
What is the current stock price of McKesson (MCK)?
What is the market cap of McKesson (MCK)?
